- Home
- CYD vs FDMT Comparison
CYD vs FDMT Comparison
Compare CYD & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYD
- FDMT
- Stock Information
- Founded
- CYD 1951
- FDMT 2013
- Country
- CYD Singapore
- FDMT United States
- Employees
- CYD N/A
- FDMT N/A
- Industry
- CYD Industrial Machinery/Components
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- CYD Industrials
- FDMT Health Care
- Exchange
- CYD Nasdaq
- FDMT Nasdaq
- Market Cap
- CYD 384.9M
- FDMT 420.7M
- IPO Year
- CYD 1994
- FDMT 2020
- Fundamental
- Price
- CYD $8.79
- FDMT $6.31
- Analyst Decision
- CYD
- FDMT Buy
- Analyst Count
- CYD 0
- FDMT 11
- Target Price
- CYD N/A
- FDMT $42.80
- AVG Volume (30 Days)
- CYD 19.7K
- FDMT 1.0M
- Earning Date
- CYD 08-12-2024
- FDMT 11-13-2024
- Dividend Yield
- CYD 4.32%
- FDMT N/A
- EPS Growth
- CYD 14.53
- FDMT N/A
- EPS
- CYD 1.17
- FDMT N/A
- Revenue
- CYD $2,639,608,357.00
- FDMT $17,000.00
- Revenue This Year
- CYD $11.68
- FDMT N/A
- Revenue Next Year
- CYD $4.06
- FDMT $87.55
- P/E Ratio
- CYD $7.51
- FDMT N/A
- Revenue Growth
- CYD 15.32
- FDMT N/A
- 52 Week Low
- CYD $7.95
- FDMT $5.58
- 52 Week High
- CYD $13.05
- FDMT $36.25
- Technical
- Relative Strength Index (RSI)
- CYD 35.05
- FDMT 36.69
- Support Level
- CYD $8.61
- FDMT $5.58
- Resistance Level
- CYD $9.45
- FDMT $7.58
- Average True Range (ATR)
- CYD 0.36
- FDMT 0.46
- MACD
- CYD 0.03
- FDMT -0.06
- Stochastic Oscillator
- CYD 17.31
- FDMT 34.93
About CYD China Yuchai International Limited
China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International primarily operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.